In this study, we have applied high-density oligonucleotide microarray technology to characterize biologic changes associated with adenoviral vector-mediated target cell infection. We infected a human melanoma cell line, M21, with the tropism-modified vectors, Ad5lucRGD and Ad5/3luc1. In addition, we infected the M21 cell line with the Ad5luc1, a vector which primarily exploits the coxsackie and adenovirus receptor, as its primary native receptor. We found significant changes in gene expression of 5492 genes induced by Ad5luc1 infection, 2439 genes induced by Ad5/3luc1 infection, and 1251 genes induced by Ad5lucRGD infection, compared to unifected cells. Among these changes in gene expression, 783 changes were common to Ad5/3luc1 and Ad5luc1 infections, 266 were common to Ad5lucRGD and Ad5luc1 infections, and 185 changes in gene expression were common to Ad5/3luc1 and Ad5lucRGD infections. Interestingly, 89 changes in gene expression were common to all the three groups, suggesting a commonly affected pathway. This analysis represents a unique application of microarray to study vector-related issues.
H uman adenovirus C vectors are attractive as gene delivery vehicles for gene therapy for several reasons. First, they can provide efficient in vivo gene transfer in both dividing and nondividing cells. 1, 2 Secondly, they possess high in vivo stability and can be produced in high titers. Thirdly and most importantly, Ad vectors are not oncogenic or integrated into the human genome and their pathology is mostly limited to mild upper respiratory tract infections. 2, 3 Unfortunately, adenoviral vectors are not without their shortcomings; preclinical and clinical trials have demonstrated limited efficacy. The predominant factor limiting the efficacy of Ad-based clinical interventions is anti-vector immunity. A contributing factor limiting the efficacy of Ad infection has been shown to be paucity of expression of the coxsackie and adenovirus receptor or CAR, which is the primary cellular receptor for serotype 5 adenovirus, on some target cells such as smooth muscle, hematopoietic cells 4 and advanced cancer. 2, 5 In this regard, retargeting strategies which redirect Ad to alternative cell receptors have been developed. 6 One tactic employs redirection of Ad to cell surface integrins which are widely expressed by incorporation of an RGD peptide motif into the HI loop of the adenovirus knob domain. 7 Another strategy retargets Ad to a receptor of subgroup B Ad, which has not yet been characterized by replacing the Ad5 knob domain with the Ad3 knob domain. 8 Retargeting of Ad to ''CARindependent'' receptors raises questions surrounding the altered biology of Ad infection.
Although the biology of Ad infection has been well characterized and extensively studied since its initial description in the early 1950s, 2,9 very little is known about the effect of Ad infection with respect to its effects on particular genes. Moreover, even less is known about the biology of tropism-modified adenoviral vectors or their effects on genes. In this regard, it is now possible to study the biological effect of recombinant adenoviral infection on genome-wide changes in gene expression as a result of the increase in the amount of DNA sequence information and the development of molecular biological techniques to exploit its use. Two extremely powerful and versatile technologies utilized for this purpose include high-density oligonucleotide and cDNA microarrays. The use of microarray technology has been minimally exploited in the field of gene therapy [10] [11] [12] [13] [14] particularly with respect to adenoviral 15, 16 vectors and their tropismmodified variants. The intent of our study was to determine differential gene expression patterns linked to a defined set of tropism-modified adenoviral vectors. To minimize cell-to-cell variables, we reasoned that this analysis would optimally be accomplished in the context of a single cellular target. We thus analyzed a wide spectrum of candidate cells to define a single line that exhibited a high level of susceptibility to the tropismmodified Ad vectors we sought to analyze. The rationale for using the human melanoma cell line, M21, was linked to our previous findings which demonstrate effective adenoviral vector-mediated infection of these melanoma cells by tropism-modified vectors, Ad5lucRGD and Ad5/ 3luc1. 17 Herein, we utilize microarray technology to investigate the resultant changes in gene expression after infection of melanoma cells with recombinant adenoviral vectors containing a wild-type capsid, Ad5luc1, or with tropism-modified adenoviral vectors Ad5lucRGD and Ad5/3luc1.
Materials and methods

Cell culture
The human melanoma cell line, M21 (kindly provided by Dr D Cheresh, CA, USA), was cultivated in RPMI 1640 (Mediatech, Herndon, VA) supplemented with 10% fetal bovine serum (FBS, HyClone, Logan, UT), 2 mM Lglutamine, 100 IU/ml penicillin, and 100 mg/ml streptomycin (all Mediatech). Cells were grown at 371C in a humidified atmosphere of 5% CO 2 .
Recombinant adenoviruses
Three replication-incompetent adenoviral vectors, Ad5-luc1, Ad5/3luc1, and Ad5lucRGD, containing a firefly luciferase transgene cassette in place of the deleted E1 region were used.
18 Ad5/3luc1, containing the tail and shaft domains of Ad serotype 5 and the knob domain of serotype 3, and Ad5lucRGD, which contains an RGD-4C peptide, CDCGRDCFC, that is incorporated in the HI loop of the fiber knob, were constructed in our laboratory as previously described. 7, 8 The viruses were propagated on 293 cells and purified on a cesium chloride gradient. The viral particle (VP) concentration was determined spectrophotometrically at 260 nm, and a standard plaque assay on 293 cells was performed to quantify infectious particles represented as plaque-forming units (PFU). The VP: PFU ratios were 4.9, 3.9, and 8.1, respectively, for Ad5luc1, Ad5/3luc1, and Ad5lucRGD. Viral titers were 1.024 Â 10 12 , 6.38 Â 10 11 , and 7.72 Â 10 11 VP/ml for Ad5-luc1, Ad5/3luc1, and Ad5lucRGD, respectively.
Ad-mediated gene transfer assays
Cells were plated in 150 Â 20 mm 2 dishes in RPMI medium as above and grown overnight at 371C and 5% CO 2 . The following day, media was removed from cell monolayers and the cells were infected with 500 VP/cell dilutions of either no virus, Ad5luc1, or the tropismmodified adenoviral vectors Ad5/3luc1 or Ad5lucRGD diluted in DMEM containing 2% FBS. Cells and virus were incubated for 45 minutes at 371C and 5% CO 2 . Subsequently, the virus was removed from cells and replaced with 20 ml of RPMI containing 10% FCS. The cells were incubated at 371C, 5% CO 2 for 30 h, washed once with PBS, trypsinized, and resuspended in RPMI.
Luciferase assay 1 ml aliquots of cells were removed for luciferase assays. After washing each aliquot with PBS, 50 ml of lysis buffer (Reporter Lysis Buffer; Promega, Madison, WI) was added to each cell pellet. Plates were incubated at room temperature for 15 minutes, and then frozen at À801C. The lysate was thawed and gene transfer luciferase expression was determined using Promega's Luciferase Assay System s (Promega).
RNA extraction
The remainder of the cells were washed once with PBS and total cellular RNA was extracted from control and adenoviral infected cells using RNeasy midi kits (Qiagen, Chatsworth, CA). The RNA concentration was determined by measuring RNA diluted 1:20 in RNAse free water and measuring the absorbance of the solution at 260 nm. The purity of the RNA was determined by calculating the ratio of RNA diluted 1:20 in Tris-HCl (10 mM, pH ¼ 7.5) at 260 and 280 nm. The RNA integrity was determined utilizing formaldehyde agarose gel electrophoresis.
Target preparation and microarray
Labeled targets were prepared using the MessageAmpt aRNA kit. Briefly, cDNA was synthesized by reverse transcription utilizing 5 mg of mRNA-rich total RNA using a T7 Oligo (dt) primer with a T7 promoter sequence. Subsequently, a second strand of cDNA was synthesized. Multiple copies of cRNA were synthesized from the doublestranded cDNA and labeled with biotinylated UTP and CTP. The labeled cRNA was fragmented and hybridized to Affymetrix s oligonucleotide microarrays. Following hybridization, the microarrays were washed, stained with streptavidin-phycoerythrin conjugate, and scanned.
Statistical analysis
The RNA was hybridization to Affymetrix Hu133A microarrays and the images were processed with MAS 5.0. A total of 20 chips were analyzed, five in each of the four groups. Quality was verified in three ways. First, a test chip was run and all RNA samples that were run have a 3 0 :5 0 ratio of no worse than 2:1. The correlation between the chips was calculated and an XXX test of correlations was run and the correlations were not found to be heterogeneous. The deleted residuals for each feature were calculated and the residuals for none of the chips were significantly different from tn-2. (Edwards et al, in preparation). Principle component analysis was conducted on the data and there were no obvious axes of separation that did not involve the known biology of the system. The data was quantile-quantile normalized and the Welch-correct t-test was used to compare the gene expression levels between the uninfected M21 cells and cells infected with Ad5luc1, Ad5/3luc1, and Ad5lucRDG vectors. The Venn diagram illustrated the number of genes, whose expression levels were significantly changed for the three comparisons. Benjamin and Hochberg FDR rates were calculated for each of the genes, as well as the Bayesian posterior probability of a true positive and true negative result was calculated using the mix-o-matic. In addition the proportion of truly differentially expressed genes was estimated. Comparing M21 vs. Ad5luc1 X%, M21 vs. Ad5lucRGD XX% and M21 vs. Ad5/3luc1 x% were differentially expressed, respectively.
Two subsets of genes were identified. (1) All those genes that were significantly different (at Po0.05) from the M21 samples and the changes in expression were in the same direction (common group). At random, three genes were expected to be in this group, but 89 were observed. (2) Those genes that were highly significant in one group (Po0.01) and nonsignificance in the other two groups (P40.2) (unique group).
All genes on the Hu133A chips were annotated with NetAffx and Dragon Database. Information that was annotated included KEGG pathway, GeneOntology Identifications, Unigene Name, Unigene number, LocusLink name, Locuslink number, Pfam domains, SwissProt domains, and site of known expression.
To objectively identify classes of differentially expressed genes, ''meta'' analysis was conducted on the GO classifications. The number of genes with a given GO classification who had a P-value of o0.01 were compared to the proportion of genes that were expected to have a P-value o0.01 using a w 2 test as implemented in Onto-Express. This was conducted in each of the three main comparisons. The most significant classes are identified in Table 1 .
Data appropriate for heat maps were calculated by dividing the expression for each feature in each of the three vector-treated groups by the mean of the feature in the M21 group. Thus, each feature becomes a ratio expression in the vector to the M21. Hierarchical clustering using average linkage clustering was conducted.
Results and discussion
To study differences in gene expression induced by infection with wild-type Ad5luc1, that contains the Ad5 wild-type capsid, and tropism-modified adenoviral vectors, Ad5lucRGD and Ad5/3luc1, we utilized Affymetrix s HG-U133A oligonucleotide microarrays and a human melanoma cell line, M21. The oligonucleotide microarrays were produced by hybridizing fragmented target cRNA to the microarray, washing away unhybridized fragments, and staining the array with a streptavidin-phycoerythrin conjugate. Subsequent laser scanning of the stained oligonucleotide microarray at 570 nm produced emitted light proportional to the amount of bound target. The light signal was converted to numerical data, which were analyzed statistically by comparing differences in the amount of bound target from cells infected with Ad5luc1, Ad5lucRGD, and Ad5/3luc1 to mock-infected M21 cells. The vectors we employed in our study were replication-incompetent based on E1A/B deletions. Furthermore, these vectors are isogenic, except for the genetic modification in the fiber ORF, which predicates altered vector tropism. Thus, all of the changes noted are exclusively attributable to the altered entry profiles dictated by the engineered modifications in tropism; even if late replication were invoked, it would be operative for each of the tested vectors and to a comparable degree. Earlier studies which utilized these vectors have demonstrated that the employed MOI elicits optimum gene transfer of target cells based on available cellular receptors. 17 We would also note that the MOIs we employed do not differ substantially from recent microarray studies of adenoviral entry biology, as noted above. 19, 20 Changes in gene expression were considered to be significant when P-values were less than 0.05. We found significant changes in gene expression levels of approximately 5472 transcripts out of approximately 39,000 transcripts representing approximately 33,000 genes induced by Ad5luc1 infection. Similarly, we found significant changes in gene expression levels of 1691 and 1168 genes induced by Ad5/3luc1 and Ad5lucRGD, respectively. We further examined changes in gene expression levels of 1000 of the most statistically significant genes by meta analysis and segregated them according to their biochemical function, biological process, cellular component, cellular role or molecular function. Our findings showed that altered gene expressions following infection of the M21 cell line with all three vectors are widespread among functional groups. Modified vector-tropism alters not only the primary receptor engaged but, in selected cases, also the overall entry pathway of the virion. 21 This consideration dictated our choice of a later time point for analysis. Our observation of clear differences between the tested Ads validates this approach. Again, studies published since our initial submission have employed time points comparable to those we have employed. 19, 20 In this regard, of the 1000 most statistically significant altered genes induced by Ad5luc1 infection, 251 of them have biochemical functions; 54 of these genes regulate transferase activity, 47 are associated with RNA binding, 39 produce proteins with inhibitor or repressor functions, and 21 are involved with receptor signaling. Out of 1000, 289 most significantly altered genes are involved in various biological processes such as RNA processing, G-protein-coupled receptor protein signaling pathway, and enzyme metabolism. Another 294 of the 1000 most statistically significantly changed genes encode for products that comprise cellular components such as neurofilament or are localized to Positive numbers indicate an increased amount mRNA, which infers an upregulation of the associated gene. Negative numbers indicate a decreased amount of mRNA, which infers a downregulation of the associated gene. NS, no statistically significant change in mRNA, level is detected. ND, no data.
a Adenovirus-associated genes. b Human homologues to genes determined by Guan et al. 23, 24 In addition to examining the 1000 most significant genes by meta analysis, we further characterized changes in gene expression by clustering the data. We identified a subset of genes that were upregulated secondary to infection with Ad5luc1 and downregulated secondary to infection with Ad5lucRGD and Ad5/3luc1 (Fig 1a) . The genes under study are represented on the right of the cluster diagram. Similarly, a subset of genes that were downregulated by Ad5luc1 infection and upregulated by Ad5lucRGD and Ad5/3luc1 infection (Fig 1b) were identified. Again, these differences are likely due to differing cell entry pathways.
After examining the data by cluster analysis and meta analysis, we examined changes in gene expression that were common and unique to each of the experimental groups. With respect to Figure 2 , Ad5lucRGD can exploit both CAR and CAR-independent pathways. However, in the context of high levels of integrin expression, this latter pathway functions as the major route of virion entry. This consideration explains the results in Figure 2 . Venn diagram (Fig 2) shows that 4333, 1381, and 710 genes are upregulated or downregulated following infection with Ad5luc1, Ad5/3luc1, and Ad5lucRGD, respectively. Of these upregulated or downregulated genes, 783 are common to Ad5luc1 and Ad5/3luc1 infection. Moreover, 266 of the differentially expressed genes are common to infection with Ad5luc1 and Ad5lucRGD, and 185 of the differentially expressed genes are common to infection with Ad5/3luc1 and Ad5lucRGD infection. Additionally, 89 genes are upregulated or downregulated with all three experimental groups (Table 2 ). These data were subjected to the Welch corrected t-test, with to0.05 being significant. Interestingly, there is significantly more overlap between genes affected by all three vectors than would be expected by chance alone, suggesting the possibility of a commonly affected pathway.
Since the cell entry pathways differ between the experimental groups examined, one may surmise that many of the changes in gene expression determined in our experiments are associated with the individual viral entry pathways. The adenovirus internalization pathway, which begins with binding of adenovirus to the coxsackie and adenovirus receptor, 25 has been well studied and characterized. 26, 27 Moreover, microarray technology has been minimally exploited with respect to the study of adenovirus-host cell interaction. [10] [11] [12] [13] [14] Therefore, further investigations of adenoviral infection may reveal unique changes in gene expression that induced at different points in its infection pathway. In this regard, we are utilizing heat-inactivated adenoviral vectors that permit binding to the cell surface receptor but do not allow internalization of the virus, 28 to study the effects of adenoviral cell surface binding on gene expression. In addition, experiments are being conducted to identify changes in gene expression associated with the interaction of recombinant Ad5 knob protein 8 with the CAR receptor. In addition, we are utilizing UV-inactivated vectors to study the effects of internalization of the virus without vector-encoded gene expression. [28] [29] [30] Clearly, many of the differences in upregulation or downregulation discovered in our experiments are associated with different viral entry mechanisms. RNA was isolated at a time point distal to complete viral entry, thus allowing for induction of entry-related gene profiles. As previously noted, Ad tropism alterations can result not just in differential employment of primary receptor but also can route the virus via an entirely alternate internalization pathway. 21 This consideration may explain the magnitude of genetic changes observed. However, other variables may contribute or be associated with the Figure 2 Venn diagram illustrating the numerical relationship between Ad5luc1, Ad5lucRGD, and Ad5/3luc1 responsive genes in the M21 human melanoma cell line. Significantly differentially expressed genes are determined utilizing the Satterweight t-test (at 0.05 and 0.01). Changes in gene expression following infection with Ad5luc1 were three times greater than changes in gene expression following Ad5/3luc1 infection and six times greater than changes in gene expression following Ad5lucRGD infection. In all, 89 of the changes in gene expression were shared by all three vectors, possibly indicating a commonly affected pathway. Unique changes in gene expression were also identified for all three vectors, indicating that different pathways are affected by each vector. Finally, microarray technology has made a major impact on many basic scientific disciplines. Many investigators are now struggling with interpretation of large data sets and communicating their findings. Moreover, while the technology may potentially provide much useful data, it also has the potential to mislead if false assumptions are made or the study design is flawed. Furthermore, technical processing steps or part of the data analysis process may lead to false-positive ornegative findings. Changes in gene expression may depend on biological parameters such as cell cycle stage, viability of cells, differentiation stage, and apoptosis. These parameters may be measured and should be used by the investigator to explain variation in experiments and allow accurate interpretation. Also, since microarray technology only detects mRNA expression levels, changes at the protein and post-translational level may not be detected. In addition, gene array and quantitative real-time PCR technologies are based on oligonucleotide hybridization and the efficiency of this hybridization can be compromised by single-point mutations in the target sequence, as substantial genetic polymorphisms exist in the human genome. Yet another possible flaw in these technologies to accurately quantify gene expression level is that some genes have alternative splicing (i.e. genes that include or skip specific exons during transcription). Therefore, caution should be taken in interpreting results from both technologies. Regarding sensitivity, gene expression arrays can detect changes in gene expression in a subpopulation of cells as small as 5% of the total. 31 On the other hand, real-time PCR can quantify mRNA expression at the single-cell level, but cells in the background might mask changes of differentially expressed genes if the efficiency of the infection or treatment is poor.
In conclusion, we have reported a novel use for oligonucleotide microarrays with respect to the field of gene therapy. Herein, we utilized the microarray to screen for changes in gene expression induced by Ad5luc1 and tropism-modified adenoviral vectors, Ad5lucRGD and Ad5/3luc1. We identified many differences in gene expression among the experimental groups. In addition, we plan to continue exploiting microarray technology to further investigate the biology of adenoviral vector infection with modified cell tropism to set up the experimental basis of potential therapeutic interventions. Table 2 Continued.
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